First Case of Coronavirus Disease 2019 in Childhood Leukemia in China

Area of Science:

• Hematology
• Infectious Diseases
• Pediatrics

Background:

• The emergence of coronavirus disease 2019 (COVID-19) has presented unique challenges in managing patients with comorbid conditions.
• Leukemia, a significant hematological malignancy, can compromise immune function, potentially altering the clinical course of viral infections.

Observation:

• This report describes the first documented case of COVID-19 in a pediatric patient with leukemia.
• The patient, hospitalized in Beijing, China, exhibited an unusually prolonged duration of symptoms and a protracted diagnostic period for COVID-19.
• The interplay between leukemia and COVID-19 infection led to a complex clinical presentation.

Findings:

• The case highlights the potential for atypical and extended symptomology of COVID-19 in immunocompromised pediatric patients.
• Diagnosis of COVID-19 was delayed due to the complexity of symptoms overlapping with leukemia-related issues.
• Nucleic acid testing and symptomatic management required careful consideration in this dual-diagnosis scenario.

Implications:

• Children with both leukemia and COVID-19 may necessitate extended isolation periods beyond standard recommendations.
• Increased frequency of nucleic acid testing is advisable for accurate diagnosis and monitoring in such cases.
• Early and tailored symptomatic treatment is crucial for managing the dual burden of leukemia and COVID-19 in pediatric patients.